NVAX - Novavax, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-657,939
-657,939
-1,743,751
-418,259
-132,694
Depreciation & amortisation
29,054
29,054
12,661
4,885
5,676
Stock-based compensation
130,300
130,300
183,626
128,035
17,048
Change in working capital
-361,150
-361,150
1,733,618
12,017
-24,018
Accounts receivable
249,166
249,166
-192,265
-422,689
-
Inventory
-477,801
-477,801
-
-
-
Accounts payable
913,399
913,399
-
-
-
Other working capital
-508,922
-508,922
265,460
-97,163
-138,480
Other non-cash items
-3,799
-3,799
136,792
230,781
6,293
Net cash provided by operating activities
-415,937
-415,937
322,946
-42,541
-136,623
Cash flows from investing activities
Investments in property, plant and equipment
-92,985
-92,985
-57,486
-54,622
-1,857
Acquisitions, net
0
0
0
-165,516
-
Purchases of investments
0
0
-2,167
-363,202
-17,484
Sales/maturities of investments
0
0
159,807
205,562
39,500
Net cash used for investing activities
-92,985
-92,985
100,154
-377,778
38,492
Cash flows from financing activities
Debt repayment
-93,595
-93,595
-127,907
-96,065
0
Common stock issued
249,230
249,230
564,859
875,623
97,392
Other financing activities
-5,258
-5,258
-
-39,087
-
Net cash used provided by (used for) financing activities
324,988
324,988
461,713
984,762
98,384
Net change in cash
-179,414
-179,414
879,521
566,558
221
Cash at beginning of period
1,528,259
1,528,259
648,738
82,180
81,959
Cash at end of period
1,348,845
1,348,845
1,528,259
648,738
82,180
Free cash flow
Operating cash flow
-415,937
-415,937
322,946
-42,541
-136,623
Capital expenditure
-92,985
-92,985
-57,486
-54,622
-1,857
Free cash flow
-508,922
-508,922
265,460
-97,163
-138,480